Latest News

NIPER Raebareli and AstraZeneca India partner to build clinical trial sites in 25 non-metro hubs

Department of Pharmaceuticals supports NIPER Raebareli–AstraZeneca collaboration to advance India’s clinical trial ecosystem under Biopharma SHAKTI

Lonza upgrades growth ambitions to target higher margins after CDMO transformation

Lonza has completed its shift to a pure-play CDMO following its exit from the Capsules & Health Ingredients business and further divestments

Enodia Therapeutics strikes Pfizer deal worth $500 million to develop novel drugs

Pfizer will take responsibility for clinical development, manufacturing, regulatory affairs and commercialisation after the collaboration term

TREMFYA shows sustained Crohn’s disease remission through three years with rates reaching 94%

Both maintenance regimens recorded an 88% rate of 90-day corticosteroid-free clinical remission

Wockhardt Hospitals Mumbai launches Da Vinci X Robotic Surgical System

The system enables surgeons to operate with greater dexterity

FUJIFILM India backs AIIMS Delhi study to boost early detection of gastrointestinal cancers

The study will evaluate whether AI-assisted endoscopy can help clinicians detect upper gastrointestinal malignancies earlier and more effectively

Souffle Therapeutics raises $135 million to advance RNA therapies into clinical trials

The funding will support the advancement of Soufflé’s three lead programs into clinical studies

Calluna Pharma completes dosing in Phase 2 IPF trial

The global trial has entered its final follow-up phase ahead of the anticipated topline results.

BPL Medical Technologies acquires majority stake in European Medec

The deal marks a significant move for the Indian medical equipment brand

ISCR and CHAKRA join forces to bridge India’s clinical research gap

Zealand Pharma and Generate Biomedicines partner to develop AI-designed obesity drugs

The partnership aims to accelerate the development of innovative treatments by using artificial intelligence to engineer proteins

Novo India slashes Norditropin FlexPro cost by 35% for growth hormone therapy

India-specific pricing to improve affordability & accessibility for children with growth disorders